Diagnostic firm Fluxergy’s pivot to Covid-testing was supposed to give it a huge boost – but even with backing from Kingston Technology’s John Tu, it’s stuck in limbo.
Why A Tech Billionaire’s $50 Million Bet On A Covid Testing Firm Is Still Waiting For FDA Approval
